ArticleUpsala journal of medical sciences2025
Factors associated with health-related quality of life 1 year after COVID-19: a cross-sectional study in Sweden.
Article in Upsala journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: The main aim of the present study was to identify factors influencing health-related quality of life (HRQoL), as measured by EQ-5D-5L, in individuals 1 year after the acute phase of COVID-19. Methods: This cross-sectional study included 75 participants (51% females), 1 year after confirmed SARS-CoV-2 infection (76% hospitalised). Associations between HRQoL, measured by patient-reported outcome measures (PROMs): EQ-5D-5L, and factors of interest, including persistent symptoms, comorbidities, work ability index (WAI), lung function, six-minute walking test (6MWT), and dyspnoea-12 (D-12) questionnaire, were assessed by an analysis of variance (ANCOVA) model (adjusted by various factors of interest) with post hoc pairwise comparison. Results: In the ANCOVA, lower HRQoL was significantly associated with not having a university education (mean difference [MD] with 95% confidence interval [CI]: 0.115 [0.013-0.217]), a higher number of persistent symptoms (for 10 vs. 1-3 symptoms: -0.153 [-0.291, -0.015]), lower work ability (for poor vs. excellent: -0.283 [-0.445, -0.120]), any comorbidity (0.077 [0.015-0.138]), and affective distress in the D-12 (0.257 [0.096-0.417]). No significant sex differences in HRQoL and the level of care at the acute infection were shown. In descriptive analysis, lower HRQoL was significantly associated with age under 55, sick leave, more dyspnoea in D-12, and poorer work ability. Conclusions: Work ability, comorbidities, persistent symptoms, and affective distress were associated with lower HRQoL at 1-year follow-up after COVID-19. No significant differences in HRQoL were observed between sexes. Our study highlights the need to address HRQoL in post-COVID-19 rehabilitation and broader public health planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.